Trial · NCT02516553
Participant flow66
How many started, completed or left each group, period by period.
1 to 20 of 66
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Phase Ia - Schedule A: 0.2 mg BI 894999 | 2 | |
| Overall Study | STARTED | Phase Ia - Schedule A: 0.5 mg BI 894999 | 2 | |
| Overall Study | STARTED | Phase Ia - Schedule A: 1 mg BI 894999 | 3 | |
| Overall Study | STARTED | Phase Ia - Schedule A: 1.5 mg BI 894999 | 6 | |
| Overall Study | STARTED | Phase Ia - Schedule A: 2 mg BI 894999 | 6 | |
| Overall Study | STARTED | Phase Ia - Schedule A: 5 mg BI 894999 | 2 | |
| Overall Study | STARTED | Phase Ia - Schedule B: 1.5 mg BI 894999 | 6 | |
| Overall Study | STARTED | Phase Ia - Schedule B: 2 mg BI 894999 | 6 | |
| Overall Study | STARTED | Phase Ia - Schedule B: 2.5 mg BI 894999 | 13 | |
| Overall Study | STARTED | Phase Ia - Schedule C: 5/2.5 mg BI 894999 | 4 | |
| Overall Study | STARTED | Phase Ia - Schedule C: 6/3 mg BI 894999 | 15 | |
| Overall Study | STARTED | Phase Ia - Schedule C: 7/3.5 mg BI 894999 | 12 | |
| Overall Study | STARTED | Phase Ia - Schedule B: 1.5 mg BI 894999 (DLBCL Patients) | 8 | |
| Overall Study | STARTED | Phase Ia - Schedule B: 2 mg BI 894999 (DLBCL Patients) | 4 | |
| Overall Study | STARTED | Phase Ia - Schedule B: 2.5 mg BI 894999 (DLBCL Patients) | 2 | |
| Overall Study | STARTED | Phase Ia - Schedule C: 4/2 mg BI 894999 (DLBCL Patients) | 2 | |
| Overall Study | STARTED | Phase Ia - Schedule C: BI 894999 5/2.5 mg (DLBCL Patients) | 2 | |
| Overall Study | STARTED | Phase Ib - Schedule B: 2 or 2.5 mg BI 894999 (SCLC Patients) | 12 | |
| Overall Study | STARTED | Phase Ib - Schedule B: 2.5 mg BI 894999 (CRC Patients) | 14 | |
| Overall Study | STARTED | Phase Ib - Schedule B: 2 or 2.5 mg BI 894999 (mCRPC Patients) | 11 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02516553/flow